Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry.
Caillet Portillo D, Puéchal X, Masson M, Kostine M, Michaut A, Ramon A, Wendling D, Costedoat-Chalumeau N, Richette P, Marotte H, Vix-Portet J, Dubost JJ, Ottaviani S, Mouterde G, Grasland A, Frazier A, Germain V, Coury F, Tournadre A, Soubrier M, Cavalie L, Brevet P, Zabraniecki L, Jamard B, Couture G, Arnaud L, Richez C, Degboé Y, Ruyssen-Witrand A, Constantin A. Caillet Portillo D, et al. Among authors: brevet p. J Infect. 2024 Feb;88(2):132-138. doi: 10.1016/j.jinf.2023.12.010. Epub 2023 Dec 22. J Infect. 2024. PMID: 38141787 Free article.
Potential efficacy of T and B lymphocyte-targeted therapies on articular involvement of patients with rheumatoid arthritis and systemic sclerosis overlap syndrome. Results from a 2-centre series of 22 cases.
Lebel N, Marie I, Grosjean J, Brevet P, Leclercq M, Dumont A, Levesque H, Benhamou Y, Marcelli C, Lequerre T, Vittecoq O. Lebel N, et al. Among authors: brevet p. Clin Exp Rheumatol. 2024 Mar 13. doi: 10.55563/clinexprheumatol/0znf7e. Online ahead of print. Clin Exp Rheumatol. 2024. PMID: 38489323
Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies.
Brevet P, Lattard C, Guillou C, Rottenberg P, Fardellone P, Le-Loët X, Lequerré T, Cosette P, Boyer O, Fréret M, Vittecoq O. Brevet P, et al. Front Immunol. 2021 Oct 7;12:733511. doi: 10.3389/fimmu.2021.733511. eCollection 2021. Front Immunol. 2021. PMID: 34691039 Free PMC article.
Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study.
Vittecoq O, Kozyreff-Meurice M, Houivet E, Leon N, Berard L, Gauthier-Prieur M, Pouplin S, Avenel G, Brevet P, Benichou J, Michelin P, Marcelli C, Lequerre T. Vittecoq O, et al. Among authors: brevet p. Clin Exp Rheumatol. 2023 May;41(5):1050-1058. doi: 10.55563/clinexprheumatol/zf8nnm. Epub 2022 Nov 12. Clin Exp Rheumatol. 2023. PMID: 36377584 Free article.
74 results